Jinhe Biology: Jinhe Holdings plans to reduce its stake in the company by no more than 3%.

On May 16, Jinhe Biology announced that the controlling shareholder Jinhe Holdings plans to reduce its holdings of the company's shares by no more than 22,563,400 shares, that is, no more than 3% of the company's total share capital, through centralized bidding transactions and block transactions from June 10, 2025 to September 9, 2025. Among them, no more than 7,521,100 shares were reduced through centralized bidding, accounting for 1% of the total share capital; No more than 15,042,300 shares were reduced through block trading, accounting for 2% of the total share capital. The reason for the reduction is to repay the pledged debt, and the price of the reduction will be determined according to the market price.